SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA, and the FARR study group. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt Study. Clin Exp Rheumatol 2006; 24 Suppl 43: S7782.
  • 2
    Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA Study): a single-blind randomised controlled trial. Lancet 2004; 364: 2639.
  • 3
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 72940.
  • 4
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 5
    Ramey DR, Raynauld JP, Fries JF. The Health Assessment Questionnaire 1992: status and review. Arthritis Care Res 1992; 5: 11929.
  • 6
    Borg G, Allander E, Lund B, Berg E, Brodin U, Pettersson H, et al. Auranofin improves outcome in early rheumatoid arthritis: results from a 2-year, double blind placebo controlled study. J Rheumatol 1988; 15: 174754.
  • 7
    Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995; 22: 220813.
  • 8
    Fitzpatrick R, Newman S, Lamb R, Shipley M. A comparison of measures of health status in rheumatoid arthritis. Br J Rheumatol 1989; 28: 2016.
  • 9
    Wolfe F, Hawley DJ, Cathey MA. Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis. J Rheumatol 1991; 18: 12907.
  • 10
    Leigh JP, Fries JF. Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis. Ann Rheum Dis 1992; 51: 5817.
  • 11
    Pincus T, Sokka T. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care. Best Pract Res Clin Rheumatol 2003; 17: 75381.
  • 12
    Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 153042.
  • 13
    Wolfe F, Hawley DJ. The long-term outcomes of rheumatoid arthritis: work disability. A prospective 18 year study of 823 patients. J Rheumatol 1998; 25: 210817.
  • 14
    Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 107282.
  • 15
    Michaud K, Messer J, Choi HK, Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum 2003; 48: 275062.
  • 16
    Department of Immunology and Rheumatology, Stanford University Department of Medicine. ARAMIS. 2003. URL: http://aramis.stanford.edu/.
  • 17
    Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 24457.
  • 18
    Bindman AB, Keane D, Lurie N. Measuring health changes among severely ill patients: the floor phenomenon. Med Care 1990; 28: 114252.
  • 19
    Wolfe F, Michaud K, Pincus T. Development and validation of the Health Assessment Questionnaire II: a revised version of the Health Assessment Questionnaire. Arthritis Rheum 2004; 50: 3296305.
  • 20
    Stucki G, Stucki S, Bruhlmann P, Michel BA. Ceiling effects of the Health Assessment Questionnaire and its modified version in some ambulatory rheumatoid arthritis patients. Ann Rheum Dis 1995; 54: 4615.
  • 21
    Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 1999; 42: 222030.
  • 22
    Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 134653.
  • 23
    Ziebland S, Fitzpatrick R, Jenkinson C, Mowat A, Mowat A. Comparison of two approaches to measuring change in health status in rheumatoid arthritis: the health assessment questionnaire (HAQ) and modified HAQ. Ann Rheum Dis 1992; 51: 12025.
  • 24
    Serrano MA, Beltran Fabregat J, Olmedo Garzon J. Should the MHAQ ever be used? [letter]. Ann Rheum Dis 1996; 55: 2712.
  • 25
    Stucki G, Stucki S, Bruhlmann P, Michel BA. Should the MHAQ ever be used? Ann Rheum Dis 1996; 55: 4615.
  • 26
    Wolfe F. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation. J Rheumatol 2001; 28: 9829.
  • 27
    Uhlig T, Kvien TK, Glennas A, Smedstad LM, Forre O. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 1998; 25: 107884.
  • 28
    Martin M, Kosinski M, Bjorner JB, Ware JE Jr, Maclean R, Li T. Item response theory methods can improve the measurement of physical function by combining the modified health assessment questionnaire and the SF-36 physical function scale. Qual Life Res 2007; 16: 64760.
  • 29
    Pincus T. A multidimensional health assessment questionnaire (MDHAQ) for all patients with rheumatic diseases to complete at all visits in standard clinical care. Bull NYU Hosp Jt Dis 2007; 65: 15060.
  • 30
    Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a MDHAQ (corrected) for standard care of patients with rheumatic diseases. J Rheumatol 2005; 32: 14329.
  • 31
    Wolfe F. Why the HAQ-II can be an effective substitute for the HAQ. Clin Exp Rheumatol 2005; 23 Suppl 39: S2930.
  • 32
    Wells GA, Tugwell P, Kraag GR, Baker PR, Groh J, Redelmeier DA. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol 1993; 20: 55760.
  • 33
    Ten Klooster PM, Taal E, van de Laar MA. Rasch analysis of the Dutch Health Assessment Questionnaire disability index and the Health Assessment Questionnaire II in patients with rheumatoid arthritis. Arthritis Rheum 2008; 59: 17218.
  • 34
    Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 2004; 116: 30511.
  • 35
    Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982; 9: 78993.
  • 36
    Stanford University School of Medicine, Division of Immunology and Rheumatology. The Health Assessment Questionnaire (HAQ) and the improved HAQ. 2009. URL: http://aramis.stanford.edu/downloads/HAQ%20Instructions%20(ARAMIS)%206-30-09.pdf.